Search results | Innovation Bridge Portal

Avril Biopharma Inc

Avril Biopharma, Inc. uses the latest biotechnologies to design, test and manufacture medicines on demand. We address the need for rapid development and production of vaccines, therapeutic and diagnostic products at affordable cost. Our opportunities are in two arenas –Global Health and Personalized Medicine. We have carefully chosen AI, genomics and synthetic biotechnologies to give every patient access to the promise of gene therapy, targeted anti-cancer therapies and many other chronic and infectious disease treatments –at an affordable price.

At present we are seeking immediate funding

Macebo Media

Macebo Media is a 100% black-owned company that was instigated for rendering a variety of ICT & Media services to anyone across Southern Africa. We offer services in Custom Development, Digital Marketing, Aerial Data Solutions, Business Process Management, and Automation. Our experienced team of experts offers tailor-made solutions to meet client requirements.

A 12-month Prospective study: A Self-reported outcome of South African population recovering from COVID-19 pandemic

The brief purpose of this study is to determine the patient-reported outcomes of participants recovering from COVID-19. This is a longitudinal study seeking to study the same population over a period of 12 months in intermittent timepoints. This study will collect data and assess the change in reported outcomes by participants over a period of 12 months. With the current design, assess the mean change averaged across the repeated outcome data. Assess the change in reported outcome over time for patients that had a mild diagnosis, acute and critical. Therefore, the primary hypothesis of the

Understanding Droplet Transmission in a Taxi

This project performs a Continuum Fluid Dynamics CFD study of droplet based transmission and airborne transmission for Tuberculosis (TB) and COVID-19 scenarios in a Taxi environments. The final goal of the study is to guide development of disruptive and innovative interventions for a Taxi to mitigate risk of transmission, despite full loads and long travel irmes, for the driver and the passengers. These interventions could be operating procedures, mechanical devices and sanitisation systems. Their efficacy must be target and deployed based on an understanding of the fluid dynamics affecting

Artificial Intelligence and Diagnosis based on Multiple Data Sources

This project is a large interdisciplinary partnership of Doctors, Public Health Researchers, Data Scientists, Physicists and Engineers. It combines the data sets represented by several sources, including images of chest X-rays, audio recordings of coughs and set sentences, and Natural Language Processing applied to clinician data of patient interviews, and possible from wearable diagnostic devices. The Artificial Intelligence (AI) solution is a weakly supervised Deep Learning network. Its novel in the range of data sources which are unified and then presented coherently to a common AI engine

Understanding Droplet Transmission in a clinical environment

This project performs a Continuum Fluid Dynamics CFD study of droplet based transmission and airborne transmission for Tuberculosis (TB) and COVID-19 scenarios in real clinical environments. The study focuses on the probability of infection for either disease as a function of the environment and how the environment is engineered. The CFD is extended to be able to model a phenomenological medical parameter of infectiousness as a function of droplet based physical, chemical and medical parameters, as they evolve in the ambient and local fluid flow environment. The local environment is realistic

Tulip Industries

Tulip Industries Ltd is a high-tech manufacturer and digital solutions integrator located in the Republic of Guinea. We aim to digitalize the Education, Government, Agriculture, Health and security sectors in developing countries primarily.

We offer a convenient and affordable way for the public to fully access the Internet and other digital content. Our workstations provide full access to web content, scanners, printers, and educational and professional applications. As the internet penetration in Africa is low, with far less smartphones per miles square in rural areas mostly, Tulip

COVID-19 TESTING - AI APPROACH

COVID-19 disease cause pulmonary infections, which could be observed by CT images of the lungs as well as chest X-ray images. Clinicians have been able to observe and diagnose similar infection such pneumonia using this approach. In fact asymptomatic breast cancer and diabetes testing can currently be done using AI image processing.

A anonymised dataset of chest x ray images of Covid-19 infected patients as well as healthy patients is sampled. A convolutional neural network model is trained to analyse chest x -ray images, detect and label COVID-19 infected cases. Mobile chest X ray machines

Makombandlela Youth Development

Makombandlela Youth Development Center was founded by the Honourable Mr. Anthony Maponya to build the general knowledge of Youth in South Africa. The center offers health, emergency, and safety issues assistance within the community in the district of Capricorn, in the Province of Limpopo. Establish in the year of 2016 registered in 2017 as a Non-Profit Organisation.

iResponse Health COVID-19 Tracker

iResponse is an AI-driven digital health platform designed to implement preventive health diagnostics, improve patient care, send out early warning and alert notification, track, predict, analyse and deal with COVID-19 infectious disease threat in Nigeria.
It helps better the human condition and bring about a better future to Nigerians using Artificial Intelligence (AI), big data analytics and digital technologies to manage and quarantine the exposed person, and deal with the pandemic in Nigeria.

Egg-based platform for design, development and manufacturing of COVID-19 countermeasures.

Avril Biopharma’s main focus is rapid development of diagnostic, vaccine and therapeutic products using bioinformatics to design these products and our AdCEV(TM) protein expression technology to produce them inexpensively in hen eggs.
We are using our platform to address the urgent public-health demand for COVID-19 diagnostic testing and safe vaccine production. We are developing simple point-of-care test-kit products including a 5-10 minute saliva test for SARS-CoV-2 infection using components we can make in hen eggs. With our high yields, enough material for thousands of individual tests

Avril Biopharma Inc

Avril Biopharma, Inc. is an emerging company founded by Dr. Eluemuno Blyden that uses the latest biotechnologies to design, test and manufacture protein-based medicines on demand. We address the need for rapid production of affordable vaccines, therapeutic antibodies and diagnostic products.

Our opportunities are in two arenas –Global Health and Personalized Medicine. We have brought together the latest AI, genomics and synthetic biotechnologies to offer every patient access to the powerful promise of gene therapy, as well as chronic and infectious disease treatments – at an affordable price

Digital Square at PATH

Digital Square focuses on creating better alignment to accelerate health equity through the development, adoption, scale, and delivery of digital health innovations. Digital Square brings partners together to improve how the global community designs, uses and pays for digital health tools and approaches. By strengthening the coordination among these partners, Digital Square reorients the market to better match tools and approaches to the needs of countries and communities.

Alignment and Co-Investment

Digital Square helps to identify promising investment opportunities and provides

PLANT-BASED SOLUTIONS TO ADDRESS THE COVID-19 PANDEMIC

Africa is highly vulnerable to the current COVID-19 pandemic. While several vaccine and antiviral candidates to prevent
COVID-19 infection are currently under development, they most likely will be expensive, difficult to transport
and distribute to remote areas and not available in sufficient quantities to administer to everyone.
Our solution is to use a plant production platform to generate vaccines, antiviral drugs and other pharmaceutical proteins. We use
our production platform to rapidly make safe vaccines which are stable at ambient temperatures, easy to scale up
and inexpensive

Strategy for pooled testing to scale up covid-19 testing capacity in The Gambia

The National Public Health Laboratory (NPHL) is the nerve center of the Gambia’s national anti-covid19 strategy. In recent weeks we have worked closely with colleagues at the MRC Unit the Gambia at LSHTM to develop COVID-19 diagnostic testing capacity at NPHL. As a COVID-19 testing center we can contribute towards increasing national testing capacity. However, with only two testing centers in the Gambia and limited resources to meet the potential demand for high numbers of tests, there is a dire need to explore innovative solutions for scaling up COVID-19 testing capacity in a short space of

Debainblue Digital

The private and the public sector needs to be able to act quickly to address society’s most pressing challenges—today more than ever. Remote work and education is a crucial resources, but to be effective, the private and public sector learners and workers need access to powerful, flexible, accelerated computing from wherever they are.

Debainblue Digital are leaders in the deployment of Ai based technologies. Our team is well-experienced in the fields of medicine, technology, and ICT. The company has shifted its focus to combating the COVID-19 pandemic in Africa. We provide not just the